Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. - Artin J; Elsabagh YA; Rashed L; Hussein MA (Archives of rheumatology, 2022)